TITLE

Metabolic Changes in Disease

AUTHOR(S)
Lehmann, H.
PUB. DATE
July 1970
SOURCE
British Medical Journal;7/11/1970, Vol. 3 Issue 5714, p94
SOURCE TYPE
Review
DOC. TYPE
Book Review
ABSTRACT
No abstract available.
ACCESSION #
64097422

 

Related Articles

  • Recognising placental steroid sulphatase deficiency. Harkness, R.A.; Taylor, N.F.; Crawford, M.A.; Rose, F.A. // British Medical Journal (Clinical Research Edition);7/2/1983, Vol. 287 Issue 6384, p2 

    Focuses on an inborn metabolic abnormality placental steroid sulphatase deficiency. Epidemiology of the disease; Manifestations of the metabolic deficiency; Treatment for the skin changes.

  • Mitochondrial Changes in Alzheimer's Disease. Breindl, Anette // BioWorld Today;3/5/2012, Vol. 23 Issue 43, Special section p2 

    The article reports on the study conducted by scientists from the Mayo Clinic on how mitochondrial metabolism changes early in the course of Alzheimer's disease.

  • Chronic obstructive pulmonary disease. 5: systemic effects of COPD. Wouters, E. F. M. // Thorax;Dec2002, Vol. 57 Issue 12, p1067 

    The role of body cell mass wasting, muscle wasting, and changes in muscle metabolism in the pathogenesis of chronic obstructive pulmonary disease is reviewed.

  • Part III--Metabolic effect of bran in patients with diverticular disease. Brodribb, A.J.M.; Humphreys, Daphne M. // British Medical Journal;2/21/1976, Vol. 1 Issue 6007, p428 

    Part III. Examines the metabolic effect of wheat bran in patients with diverticular disease in Berkshire, England. Administration of bran to patients for six months; Changes in the metabolism of patients following the treatment; Widespread use of bran in the treatment of diverticular diseases.

  • Mutation analysis in metabolic (and other genetic) disease: how soon, how useful. Scriver, Charles R. // European Journal of Pediatrics;2000, Vol. 159 Issue 15, pS243 

    Presents a summary of a symposium on the changes in clinical practice on mutation analysis in metabolic diseases in November 1999 in Germany. Changes in disease phenotypes in the 20th century; Genetic screening and testing; Information on mutation which contribute to the cause of diseases.

  • Alzheimer Disease: Clinical and Biological Heterogeneity. Friedland, Robert P.; koss, Elizabeth; Haxby, James V.; Grady, Cheryl L.; Luxenburg, Jay; Schapiro, Mark B.; Kaye, Jeffrey // Annals of Internal Medicine;8/15/88, Vol. 109 Issue 4, p298 

    Focuses on the clinical and biological heterogeneity of Alzheimer's disease. Variability of clinical manifestations of the disease; Changes in noncognitive behaviors of patients with the disease; Heterogenous patterns of regional cerebral glucose use; Longitudinal changes in brain metabolism.

  • Mutation analysis in metabolic disease - change in clinical practice? Zschocke, Johannes; Steinmann, Beat; Hoffmann, Georg F. // European Journal of Pediatrics;2000, Vol. 159 Issue 15, pS169 

    Presents information on the symposium on changes in clinical practice with regard to mutation analysis in metabolic disease in November 1999 in Germany. Progress in the molecular understanding of inborn errors of metabolism; Issues discussed during the symposium.

  • CIRRHOSIS OF THE LIVER: ITS RELATIONSHIP TO CHOLESTEROSIS OF THE GALLBLADDER, GALLSTONES AND OTHER CONDITIONS. AN AUTOPSY STUDY. Feldman, Maurice; Feldman Jr., Maurice // American Journal of Gastroenterology;May1955, Vol. 23 Issue 5, p435 

    Examines the disturbance of cholesterol metabolism plays a major role in cardiovascular disease and in cholesterosis of the gallbladder. Etiology of cholesterosis of the gallbladder and gallstones; Significance of liver in lipid metabolism; Causes of changes in the blood levels of cholesterol...

  • Studies of the Blood Ammonia in Liver Disease. Stahl, Jules // Annals of Internal Medicine;Jan63, Vol. 58 Issue 1, p1 

    Investigates ammonia metabolism in liver diseases. Ammonia tolerance test in uncomplicated cirrhosis with simultaneous arterial and venous ammonia measurements; Distinction between hepatic and extrahepatic ammonia metabolism; Electroencephalographic changes.

  • Renal Disease and the Metabolic Effects of Tetracycline. Shils, Maurice E. // Annals of Internal Medicine;Mar63, Vol. 58 Issue 3, p389 

    Examines the metabolic effects of tetracycline. Changes in blood urea nitrogen and blood chemistry; Effects of tetracycline in patients with renal disease; Symptomatic reactions to tetracycline.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics